Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap78.57M
Enterprise Value38.12M
Trailing P/E2.52
QTTB
(NASDAQ)Q32 Bio Inc.
$6.38-- (--)
Loading... - Market loading
Q32 Bio (QTTB) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Forward Price/Sales9.37
Price/Book (mrq)1.79
Price/Tangible Book (mrq)1.79
Enterprise Value Ratios
EV-based valuation multiples
EV/Earnings1.28
EV/EBITDA1.99
EV/EBIT-1.87
Stock Price
Current price, 52-week range, and moving averages
Current Price$6.38
1-Day Change-4.83%
52-Week High$8.05
52-Week Low$1.35
52-Week Change307.33%
YTD Change77.62%
1-Year Change311.45%
50-Day MA$5.07
200-Day MA$3.08
Avg Volume (30 day)166.53K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding12.31M
Book Value per Share$3.41
Net Cash per Share$3.42
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$13.00
Target Upside/Downside103.76%
Analyst ConsensusBuy
Analyst Count1
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)70.98%
Return on Assets (ttm)48.27%
Return on Invested Capital (ttm)-417.16%
Return on Capital Employed (ttm)-40.49%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue0.00
Gross Profit-91.00K
Operating Income16.90M
Pretax Income29.82M
Net Income29.82M
EBITDA19.17M
EBIT-20.42M
Diluted EPS$2.37
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow-27.36M
Growth Rates (YoY)
Year-over-year growth metrics
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)61.78M
Cash & Securities (mrq)48.30M
Net Cash (mrq)42.06M
Net Cash per Share$3.42
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)11.18M
Working Capital (mrq)43.70M
Total Equity (mrq)42.01M
Book Value per Share$3.41
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)4.85
Quick Ratio (mrq)4.85
Debt/Equity (mrq)0.27
Debt/EBITDA (ttm)0.58
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield39.63%
Buyback Yield0.00%
Total Shareholder Yield0.00%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score-2.60
Piotroski F-Score3/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$13.48
Graham Upside/Downside120.67%
Frequently Asked Questions About Q32 Bio Statistics
What are the key financial metrics for QTTB?
Q32 Bio Inc. (QTTB) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is QTTB's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Q32 Bio is overvalued or undervalued.
How do I read QTTB's profitability ratios?
Q32 Bio's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do QTTB's debt ratios indicate?
The financial health section shows Q32 Bio's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is QTTB's dividend analysis?
The dividend section covers Q32 Bio's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.